300238 冠昊生物
已收盘 08-23 15:00:00
资讯
新帖
简况
冠昊生物:目前公司开展的生物人工肝项目处于临床前研究阶段
证券之星 · 08-19
冠昊生物:目前公司开展的生物人工肝项目处于临床前研究阶段
冠昊生物(300238)8月13日主力资金净卖出596.51万元
证券之星 · 08-13
冠昊生物(300238)8月13日主力资金净卖出596.51万元
【人脑工程概念走强 复旦复华涨超8%】 人脑工程概念走强,截至发稿,复旦复华涨超8%,航天长峰、博济医药、冠昊生物、国际医学、北陆药业等涨幅居前。
智通财经 · 08-02
【人脑工程概念走强 复旦复华涨超8%】 人脑工程概念走强,截至发稿,复旦复华涨超8%,航天长峰、博济医药、冠昊生物、国际医学、北陆药业等涨幅居前。
冠昊生物最新公告:聘任张伟坤为公司副总经理、易若峰为财务负责人
证券之星 · 07-30
冠昊生物最新公告:聘任张伟坤为公司副总经理、易若峰为财务负责人
【冠昊生物(300238.SZ)聘任易若峰为财务负责人】智通财经APP讯,冠昊生物(300238.SZ)公告,公司董事会于近日收到张伟坤递交的辞职报告,张伟坤因工作调整原因,申请辞去公司财务负责人职务,其原定任期为第六届董事会届满之日止。
智通财经 · 07-30
【冠昊生物(300238.SZ)聘任易若峰为财务负责人】智通财经APP讯,冠昊生物(300238.SZ)公告,公司董事会于近日收到张伟坤递交的辞职报告,张伟坤因工作调整原因,申请辞去公司财务负责人职务,其原定任期为第六届董事会届满之日止。
冠昊生物(300238.SZ)聘任易若峰为财务负责人
智通财经网 · 07-30
冠昊生物(300238.SZ)聘任易若峰为财务负责人
冠昊生物:公司研发项目情况请参见公司2023年年度报告中的相关内容
证券之星 · 07-26
冠昊生物:公司研发项目情况请参见公司2023年年度报告中的相关内容
冠昊生物:截止2024年7月19日,公司股东总户数为31960
证券之星 · 07-22
冠昊生物:截止2024年7月19日,公司股东总户数为31960
冠昊生物(300238)7月22日主力资金净卖出877.70万元
证券之星 · 07-22
冠昊生物(300238)7月22日主力资金净卖出877.70万元
冠昊生物最新公告:控股股东广东知光部分股份可能被司法强制执行
证券之星 · 07-19
冠昊生物最新公告:控股股东广东知光部分股份可能被司法强制执行
冠昊生物:截止2024年7月10日,公司股东总户数为32054
证券之星 · 07-17
冠昊生物:截止2024年7月10日,公司股东总户数为32054
冠昊生物:截止2024年6月28日,公司股东总户数为32823
证券之星 · 07-02
冠昊生物:截止2024年6月28日,公司股东总户数为32823
09:25 三大指数集体低开,沪指低开0.06%,深成指低开0.15%,创业板指低开0.3% 09:26 脑机接口概念开盘领涨,创新医疗涨停,爱朋医疗、三博脑科、冠昊生物、南京熊猫等纷纷高开09:28 财税改革概念股继续大涨,税友股份6天5板,普联软件、久其软件一字涨停,旋极信息涨超10%,科创信息、中科江南等多股高开 09:40 地产股再度拉升,荣丰控股直线涨停,新黄浦、万通发展、光明地产、绿地控股、滨江集团等跟涨 09:52 土地流转、乡村振兴概念延续强势,辉隆股份2连板,永安林业涨停,神农科技涨超10%,上实发展、亚通股份、中农联合、亚盛集团等涨幅靠前 09:58 工程机械板块大幅下挫,山推股份、徐工机械跌近8%,杭叉集团、浙江鼎力、柳工、安徽合力跌超5% 10:31 智能电网概念反复活跃,大烨智能直线拉升涨超15%,三晖电气5连板,科林电气、煜邦电力、中电兴发、万胜智能等涨幅居前 10:46 白酒股震荡走高,金种子酒涨超8%,贵州茅台、皇台酒业、舍得酒业、金徽酒、今世缘等涨超3% 11:10 维生素概念股继续走强,兄弟科技冲击涨停,花园生物涨超10%,广济药业、金达威、新赣江等涨幅居前
华尔街见闻 · 07-02
09:25 三大指数集体低开,沪指低开0.06%,深成指低开0.15%,创业板指低开0.3% 09:26 脑机接口概念开盘领涨,创新医疗涨停,爱朋医疗、三博脑科、冠昊生物、南京熊猫等纷纷高开09:28 财税改革概念股继续大涨,税友股份6天5板,普联软件、久其软件一字涨停,旋极信息涨超10%,科创信息、中科江南等多股高开 09:40 地产股再度拉升,荣丰控股直线涨停,新黄浦、万通发展、光明地产、绿地控股、滨江集团等跟涨 09:52 土地流转、乡村振兴概念延续强势,辉隆股份2连板,永安林业涨停,神农科技涨超10%,上实发展、亚通股份、中农联合、亚盛集团等涨幅靠前 09:58 工程机械板块大幅下挫,山推股份、徐工机械跌近8%,杭叉集团、浙江鼎力、柳工、安徽合力跌超5% 10:31 智能电网概念反复活跃,大烨智能直线拉升涨超15%,三晖电气5连板,科林电气、煜邦电力、中电兴发、万胜智能等涨幅居前 10:46 白酒股震荡走高,金种子酒涨超8%,贵州茅台、皇台酒业、舍得酒业、金徽酒、今世缘等涨超3% 11:10 维生素概念股继续走强,兄弟科技冲击涨停,花园生物涨超10%,广济药业、金达威、新赣江等涨幅居前
爱朋医疗、三博脑科、冠昊生物、南京熊猫等纷纷高开,消息上,工信部脑机接口标准化技术委员会筹建方案公示,成立后工作计划包括优化完善标准化路线图、加快关键技术标准研制、推动标准宣贯实施。
华尔街见闻 · 07-02
爱朋医疗、三博脑科、冠昊生物、南京熊猫等纷纷高开,消息上,工信部脑机接口标准化技术委员会筹建方案公示,成立后工作计划包括优化完善标准化路线图、加快关键技术标准研制、推动标准宣贯实施。
脑机接口概念开盘领涨,创新医疗涨停,爱朋医疗、三博脑科、冠昊生物、南京熊猫等纷纷高开,消息上,工信部脑机接口标准化技术委员会筹建方案公示,成立后工作计划包括优化完善标准化路线图、加快关键技术标准研制、推动标准宣贯实施。
华尔街见闻 · 07-02
脑机接口概念开盘领涨,创新医疗涨停,爱朋医疗、三博脑科、冠昊生物、南京熊猫等纷纷高开,消息上,工信部脑机接口标准化技术委员会筹建方案公示,成立后工作计划包括优化完善标准化路线图、加快关键技术标准研制、推动标准宣贯实施。
干细胞概念盘中跳水,冠昊生物跌0.78%
自选股智能写手 · 07-01
干细胞概念盘中跳水,冠昊生物跌0.78%
冠昊生物获得实用新型专利授权:“省力式活塞驱动结构”
证券之星 · 06-26
冠昊生物获得实用新型专利授权:“省力式活塞驱动结构”
冠昊生物:截止2024年6月20日,公司股东总户数为32863
证券之星 · 06-24
冠昊生物:截止2024年6月20日,公司股东总户数为32863
冠昊生物:公司研发项目情况请参见公司2023年年度报告中的相关内容
证券之星 · 06-07
冠昊生物:公司研发项目情况请参见公司2023年年度报告中的相关内容
【企业动态】冠昊生物新增1件法院诉讼,案由为建设工程施工合同纠纷
证券之星 · 05-24
【企业动态】冠昊生物新增1件法院诉讼,案由为建设工程施工合同纠纷
加载更多
公司概况
公司名称:
冠昊生物科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2011-07-06
主营业务:
冠昊生物科技股份有限公司是一家从事再生医学材料及再生型医用植入器械研发、生产及销售的高科技企业。公司主要从事研究、开发、生产:Ⅱ类、Ⅲ类:6846植入材料和人工器官,6846医用卫生材料及敷料;销售自产产品及提供服务;三类、二类:植入材料和人工器官,医用卫生材料及敷料的批发、零售。公司的技术研究和产品开发紧跟国家发展方向,目前公司参与了两项“十三五”国家重点研发计划,均是围绕组织修复与可再生材料进行技术创新和新产品开发。
发行价格:
18.20
{"stockData":{"symbol":"300238","market":"SZ","secType":"STK","nameCN":"冠昊生物","latestPrice":8.58,"timestamp":1724396610000,"preClose":8.65,"halted":0,"volume":2676500,"delay":0,"floatShares":265000000,"shares":265000000,"eps":0.0879,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.07,"latestTime":"08-23 15:00:00","open":8.65,"high":8.75,"low":8.53,"amount":23004400,"amplitude":0.0254,"askPrice":8.58,"askSize":29,"bidPrice":8.57,"bidSize":172,"shortable":0,"etf":0,"ttmEps":0.0879,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724635800000},"adr":0,"adjPreClose":8.65,"symbolType":"stock","openAndCloseTimeList":[[1724376600000,1724383800000],[1724389200000,1724396400000]],"highLimit":9.52,"lowLimit":7.79,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":265155701,"pbRate":4.29,"roa":"--","roe":"2.73%","epsLYR":0.12,"committee":0.083272,"marketValue":2275000000,"floatMarketCap":2275000000,"peRate":97.610924,"changeRate":-0.0081,"turnoverRate":0.0101,"status":1},"requestUrl":"/m/hq/s/300238","defaultTab":"news","newsList":[{"id":"2460086171","title":"冠昊生物:目前公司开展的生物人工肝项目处于临床前研究阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2460086171","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460086171?lang=zh_cn&edition=full","pubTime":"2024-08-19 18:01","pubTimestamp":1724061690,"startTime":"0","endTime":"0","summary":"证券之星消息,冠昊生物08月19日在投资者关系平台上答复投资者关心的问题。请问现在有没有进行临床申报?目前公司开展的生物人工肝项目处于临床前研究阶段。还有美国的联营公司ZY Therapeutics Inc与美迪西2022年签署了临床前IND申报服务战略合作,是否有新药已经申请临床申报?公司研发项目情况请参见公司2023年年度报告中的相关内容。感谢您的关注与支持!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081900024680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300238","BK0077","BK0042","BK0251","BK0086","BK0046"],"gpt_icon":0},{"id":"2459153942","title":"冠昊生物(300238)8月13日主力资金净卖出596.51万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459153942","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459153942?lang=zh_cn&edition=full","pubTime":"2024-08-13 15:24","pubTimestamp":1723533883,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年8月13日收盘,冠昊生物报收于9.15元,下跌1.61%,换手率2.73%,成交量7.23万手,成交额6584.08万元。8月13日的资金流向数据方面,主力资金净流出596.51万元,占总成交额9.06%,游资资金净流出761.12万元,占总成交额11.56%,散户资金净流入1357.63万元,占总成交额20.62%。冠昊生物主营业务:生产和销售医疗器械、药品及提供细胞技术服务等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081300025226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0251","BK0042","300238","BK0046","BK0086"],"gpt_icon":0},{"id":"2456117674","title":"【人脑工程概念走强 复旦复华涨超8%】 人脑工程概念走强,截至发稿,复旦复华涨超8%,航天长峰、博济医药、冠昊生物、国际医学、北陆药业等涨幅居前。","url":"https://stock-news.laohu8.com/highlight/detail?id=2456117674","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456117674?lang=zh_cn&edition=full","pubTime":"2024-08-02 09:56","pubTimestamp":1722563787,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["300016","BK0181","BK0037","BK0114","BK0075","BK0058","300404","BK0010","BK0077","BK0086","BK0251","BK0096","BK0041","000516","300238","BK0042","BK0188","BK0236","BK0046","600855","BK0239","BK0216","600624","BK0122","BK0060","BK0146"],"gpt_icon":0},{"id":"2455607104","title":"冠昊生物最新公告:聘任张伟坤为公司副总经理、易若峰为财务负责人","url":"https://stock-news.laohu8.com/highlight/detail?id=2455607104","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455607104?lang=zh_cn&edition=full","pubTime":"2024-07-30 16:50","pubTimestamp":1722329402,"startTime":"0","endTime":"0","summary":"冠昊生物公告,公司第六届董事会第八次会议,审议通过了《关于聘任公司副总经理的议案》、《关于聘任公司财务负责人的议案》。公司董事会同意聘任张伟坤为公司副总经理,兼任风控总监;聘任易若峰为公司财务负责人。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073000032269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300238","BK0042","BK0046","BK0086","BK0251","BK0077"],"gpt_icon":0},{"id":"2455602408","title":"【冠昊生物(300238.SZ)聘任易若峰为财务负责人】智通财经APP讯,冠昊生物(300238.SZ)公告,公司董事会于近日收到张伟坤递交的辞职报告,张伟坤因工作调整原因,申请辞去公司财务负责人职务,其原定任期为第六届董事会届满之日止。","url":"https://stock-news.laohu8.com/highlight/detail?id=2455602408","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455602408?lang=zh_cn&edition=full","pubTime":"2024-07-30 16:44","pubTimestamp":1722329077,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0077","BK0042","300238","BK0046","BK0086","BK0251"],"gpt_icon":0},{"id":"2455022536","title":"冠昊生物(300238.SZ)聘任易若峰为财务负责人","url":"https://stock-news.laohu8.com/highlight/detail?id=2455022536","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455022536?lang=zh_cn&edition=full","pubTime":"2024-07-30 16:44","pubTimestamp":1722329077,"startTime":"0","endTime":"0","summary":"智通财经APP讯,冠昊生物(300238.SZ)公告,公司董事会于近日收到张伟坤递交的辞职报告,张伟坤因工作调整原因,申请辞去公司财务负责人职务,其原定任期为第六届董事会届满之日止。辞职后,张伟坤将担任公司副总经理兼风控总监职务。公司董事会同意聘任易若峰为公司财务负责人,任期自董事会审议通过之日起至第六届董事会届满之日止。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1157408.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0042","300238","BK0077","BK0086","BK0251","BK0046"],"gpt_icon":0},{"id":"2454317089","title":"冠昊生物:公司研发项目情况请参见公司2023年年度报告中的相关内容","url":"https://stock-news.laohu8.com/highlight/detail?id=2454317089","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454317089?lang=zh_cn&edition=full","pubTime":"2024-07-26 19:02","pubTimestamp":1721991747,"startTime":"0","endTime":"0","summary":"证券之星消息,冠昊生物(300238)07月26日在投资者关系平台上答复投资者关心的问题。投资者:贵公司参股的美国ZY公司研究成果主要是什么?进度如何?冠昊生物董秘:尊敬的投资者您好!公司研发项目情况请参见公司2023年年度报告中的相关内容。感谢您的关注与支持!以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072600042715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300238","BK0086","BK0077","BK0042","BK0046"],"gpt_icon":0},{"id":"2453576997","title":"冠昊生物:截止2024年7月19日,公司股东总户数为31960","url":"https://stock-news.laohu8.com/highlight/detail?id=2453576997","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453576997?lang=zh_cn&edition=full","pubTime":"2024-07-22 18:04","pubTimestamp":1721642667,"startTime":"0","endTime":"0","summary":"证券之星消息,冠昊生物(300238)07月22日在投资者关系平台上答复投资者关心的问题。投资者:请问截止2024年7月20日,公司股东人数多少?冠昊生物董秘:尊敬的投资者您好!截止2024年7月19日,公司股东总户数为31960。感谢您的关注与支持!以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200024921.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0086","BK0042","300238","BK0251","BK0046"],"gpt_icon":0},{"id":"2453379587","title":"冠昊生物(300238)7月22日主力资金净卖出877.70万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453379587","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453379587?lang=zh_cn&edition=full","pubTime":"2024-07-22 15:22","pubTimestamp":1721632957,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月22日收盘,冠昊生物报收于8.53元,下跌4.16%,换手率3.26%,成交量8.64万手,成交额7336.95万元。7月22日的资金流向数据方面,主力资金净流出877.7万元,占总成交额11.96%,游资资金净流出16.88万元,占总成交额0.23%,散户资金净流入894.59万元,占总成交额12.19%。冠昊生物主营业务:生产和销售医疗器械、药品及提供细胞技术服务等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200013625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0077","BK0251","BK0086","BK0046","300238"],"gpt_icon":0},{"id":"2452742504","title":"冠昊生物最新公告:控股股东广东知光部分股份可能被司法强制执行","url":"https://stock-news.laohu8.com/highlight/detail?id=2452742504","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452742504?lang=zh_cn&edition=full","pubTime":"2024-07-19 18:30","pubTimestamp":1721385017,"startTime":"0","endTime":"0","summary":"冠昊生物公告,公司收到控股股东广东知光生物科技有限公司(“广东知光”)《告知函》,获悉广东知光近日收到《广东省广州市荔湾区人民法院执行裁定书》,申请执行人为何莉,被执行人为广东知光生物科技有限公司。公司控股股东广东知光表示,其所持有的公司部分股份存在被司法强制执行而发生变动的可能。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071900042109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","300238","BK0077","BK0042","BK0046","BK0251"],"gpt_icon":0},{"id":"2452613996","title":"冠昊生物:截止2024年7月10日,公司股东总户数为32054","url":"https://stock-news.laohu8.com/highlight/detail?id=2452613996","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452613996?lang=zh_cn&edition=full","pubTime":"2024-07-17 18:04","pubTimestamp":1721210647,"startTime":"0","endTime":"0","summary":"证券之星消息,冠昊生物07月17日在投资者关系平台上答复投资者关心的问题。根据《深圳证券交易所创业板股票上市规则》,创业板上市公司半年报业绩预告不属于强制性披露信息,公司严格按照上市规则等相关法律法规要求履行信息披露义务。关于公司2024年半年度经营情况,敬请关注公司后续披露的半年度报告。截止2024年7月10日,公司股东总户数为32054。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700037564.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0046","BK0077","300238","BK0086","BK0042"],"gpt_icon":0},{"id":"2448958132","title":"冠昊生物:截止2024年6月28日,公司股东总户数为32823","url":"https://stock-news.laohu8.com/highlight/detail?id=2448958132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448958132?lang=zh_cn&edition=full","pubTime":"2024-07-02 19:01","pubTimestamp":1719918103,"startTime":"0","endTime":"0","summary":"证券之星消息,冠昊生物(300238)07月02日在投资者关系平台上答复投资者关心的问题。投资者:请问,2024年6月28日收盘,贵司的股东人数是多少?谢谢!冠昊生物董秘:尊敬的投资者您好!截止2024年6月28日,公司股东总户数为32823。感谢您的关注与支持!以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070200029106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300238","BK0042","BK0086","BK0251","BK0077","BK0046"],"gpt_icon":0},{"id":"2448903592","title":"09:25 三大指数集体低开,沪指低开0.06%,深成指低开0.15%,创业板指低开0.3% 09:26 脑机接口概念开盘领涨,创新医疗涨停,爱朋医疗、三博脑科、冠昊生物、南京熊猫等纷纷高开09:28 财税改革概念股继续大涨,税友股份6天5板,普联软件、久其软件一字涨停,旋极信息涨超10%,科创信息、中科江南等多股高开 09:40 地产股再度拉升,荣丰控股直线涨停,新黄浦、万通发展、光明地产、绿地控股、滨江集团等跟涨 09:52 土地流转、乡村振兴概念延续强势,辉隆股份2连板,永安林业涨停,神农科技涨超10%,上实发展、亚通股份、中农联合、亚盛集团等涨幅靠前 09:58 工程机械板块大幅下挫,山推股份、徐工机械跌近8%,杭叉集团、浙江鼎力、柳工、安徽合力跌超5% 10:31 智能电网概念反复活跃,大烨智能直线拉升涨超15%,三晖电气5连板,科林电气、煜邦电力、中电兴发、万胜智能等涨幅居前 10:46 白酒股震荡走高,金种子酒涨超8%,贵州茅台、皇台酒业、舍得酒业、金徽酒、今世缘等涨超3% 11:10 维生素概念股继续走强,兄弟科技冲击涨停,花园生物涨超10%,广济药业、金达威、新赣江等涨幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2448903592","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448903592?lang=zh_cn&edition=full","pubTime":"2024-07-02 11:43","pubTimestamp":1719891819,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["603171","603298","159982","002562","603050","002626","600692","603338","603919","83189","600246","000995","300996","600638","03189","603369","688597","300189","600775","399001","600761","000425","300670","300882","300324","002279","399006","000528","159542","600702","000952","300753","002556","000680","301153","002857","600606","600748","300401","600708","002173","000663","600108","000668","600199","000682.SH","300238","002298","600519","003042"],"gpt_icon":0},{"id":"2448752229","title":"爱朋医疗、三博脑科、冠昊生物、南京熊猫等纷纷高开,消息上,工信部脑机接口标准化技术委员会筹建方案公示,成立后工作计划包括优化完善标准化路线图、加快关键技术标准研制、推动标准宣贯实施。","url":"https://stock-news.laohu8.com/highlight/detail?id=2448752229","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448752229?lang=zh_cn&edition=full","pubTime":"2024-07-02 09:26","pubTimestamp":1719883577,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK0188","BK0214","BK0130","600775","300753","BK0042","BK0046","BK0061","BK0086","BK0236","BK0251","BK0077","300238","301293"],"gpt_icon":0},{"id":"2448097568","title":"脑机接口概念开盘领涨,创新医疗涨停,爱朋医疗、三博脑科、冠昊生物、南京熊猫等纷纷高开,消息上,工信部脑机接口标准化技术委员会筹建方案公示,成立后工作计划包括优化完善标准化路线图、加快关键技术标准研制、推动标准宣贯实施。","url":"https://stock-news.laohu8.com/highlight/detail?id=2448097568","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448097568?lang=zh_cn&edition=full","pubTime":"2024-07-02 09:26","pubTimestamp":1719883577,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK0086","BK0096","BK0061","BK0236","300238","600775","BK0077","BK0114","BK0214","300753","002173","BK0042","BK0130","BK0046","301293","BK0188","BK0251"],"gpt_icon":0},{"id":"2448322931","title":"干细胞概念盘中跳水,冠昊生物跌0.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448322931","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448322931?lang=zh_cn&edition=full","pubTime":"2024-07-01 10:11","pubTimestamp":1719799871,"startTime":"0","endTime":"0","summary":"07月01日,干细胞概念盘中跳水,截至10点11分,干细胞概念整体指数下跌1.02%,报658.100点。从个股上来看,该概念的成分股中,冠昊生物跌0.78%,中源协和、南京新百、华邦健康跌幅居前。从资金上来看,截止发稿,干细胞概念主力净流入为-1282.23万,其中中源协和受到资金热捧,主力净流入305.42万;拉长时间线来看,该板块近20日主力资金净流入-13.55亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701101111941f2927&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701101111941f2927&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300238","BK0042","BK0086","BK0251","BK0216","600645","BK0239","BK0077","BK0188","BK0046"],"gpt_icon":0},{"id":"2446787849","title":"冠昊生物获得实用新型专利授权:“省力式活塞驱动结构”","url":"https://stock-news.laohu8.com/highlight/detail?id=2446787849","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446787849?lang=zh_cn&edition=full","pubTime":"2024-06-26 02:56","pubTimestamp":1719341764,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示冠昊生物新获得一项实用新型专利授权,专利名为“省力式活塞驱动结构”,专利申请号为CN202322967610.6,授权日为2024年6月11日。螺杆具有拨块;拨块插接于插孔,并与联动回转结构联动连接;螺杆能够相对于联动回转结构转动,以使拨块能够转动至与轴向回退联动限位台相互轴向限位的位置处。今年以来冠昊生物新获得专利授权1个,与去年同期持平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062600004360.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","300238","BK0077","BK0086","BK0251","BK0046"],"gpt_icon":0},{"id":"2445029411","title":"冠昊生物:截止2024年6月20日,公司股东总户数为32863","url":"https://stock-news.laohu8.com/highlight/detail?id=2445029411","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445029411?lang=zh_cn&edition=full","pubTime":"2024-06-24 18:04","pubTimestamp":1719223471,"startTime":"0","endTime":"0","summary":"证券之星消息,冠昊生物(300238)06月24日在投资者关系平台上答复投资者关心的问题。投资者:请问截止到2024年6月20日股东户数是多少?谢谢冠昊生物董秘:尊敬的投资者您好!截止2024年6月20日,公司股东总户数为32863。感谢您的关注与支持!以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062400026255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0077","BK0251","BK0086","BK0046","300238"],"gpt_icon":0},{"id":"2441053165","title":"冠昊生物:公司研发项目情况请参见公司2023年年度报告中的相关内容","url":"https://stock-news.laohu8.com/highlight/detail?id=2441053165","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441053165?lang=zh_cn&edition=full","pubTime":"2024-06-07 18:03","pubTimestamp":1717754589,"startTime":"0","endTime":"0","summary":"证券之星消息,冠昊生物06月07日在投资者关系平台上答复投资者关心的问题。投资者:请问贵公司最近多年,年销售额4亿左右,是市场饱和了吗?公司核心业务为材料、药业、细胞三大业务板块,各业务板块的市场情况请参见公司近年来的定期报告。公司研发项目情况请参见公司2023年年度报告中的相关内容。感谢您的关注与支持!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060700036993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300238","BK0077","BK0046","BK0086","BK0042"],"gpt_icon":0},{"id":"2437712729","title":"【企业动态】冠昊生物新增1件法院诉讼,案由为建设工程施工合同纠纷","url":"https://stock-news.laohu8.com/highlight/detail?id=2437712729","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437712729?lang=zh_cn&edition=full","pubTime":"2024-05-24 05:56","pubTimestamp":1716501382,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,5月10日冠昊生物(300238)新增1件法院诉讼如下:案号:(2024)粤01民终13578号法院:广东省广州市中级人民法院案由:建设工程施工合同纠纷原告:广州市坤龙建筑安装工程有限公司被告:广东益安人防工程科技有限公司、冠昊生物科技股份有限公司案件类型:民事立案日期:2024年5月10日数据来源:企查查以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052400010234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0086","BK0077","BK0046","300238","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2011-07-06","address":"广东省广州市黄埔区玉岩路12号","stockEarnings":[{"period":"1week","weight":-0.0804},{"period":"1month","weight":0.035},{"period":"3month","weight":-0.1694},{"period":"6month","weight":-0.1563},{"period":"1year","weight":-0.3228},{"period":"ytd","weight":-0.3673}],"companyName":"冠昊生物科技股份有限公司","boardCode":"AI0035","perCapita":"7979股","boardName":"专用设备制造业","registeredCapital":"26515万元","compareEarnings":[{"period":"1week","weight":-0.0087},{"period":"1month","weight":-0.0164},{"period":"3month","weight":-0.0759},{"period":"6month","weight":-0.0501},{"period":"1year","weight":-0.0739},{"period":"ytd","weight":-0.0405}],"survey":" 冠昊生物科技股份有限公司是一家从事再生医学材料及再生型医用植入器械研发、生产及销售的高科技企业。公司主要从事研究、开发、生产:Ⅱ类、Ⅲ类:6846植入材料和人工器官,6846医用卫生材料及敷料;销售自产产品及提供服务;三类、二类:植入材料和人工器官,医用卫生材料及敷料的批发、零售。公司的技术研究和产品开发紧跟国家发展方向,目前公司参与了两项“十三五”国家重点研发计划,均是围绕组织修复与可再生材料进行技术创新和新产品开发。","serverTime":1724513892285,"listedPrice":18.2,"stockholders":"33226人(较上一季度增加3.82%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"冠昊生物(300238)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供冠昊生物(300238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"冠昊生物,300238,冠昊生物股票,冠昊生物股票老虎,冠昊生物股票老虎国际,冠昊生物行情,冠昊生物股票行情,冠昊生物股价,冠昊生物股市,冠昊生物股票价格,冠昊生物股票交易,冠昊生物股票购买,冠昊生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"冠昊生物(300238)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供冠昊生物(300238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}